Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
The Journal of Urology
|
February 1, 1988
Isolated renal artery dissection secondary to medial degeneration
R Goldfarb, J L Pool, T Wheeler
Journal of Human Hypertension
|
October 1, 1990
Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations
J L Pool, M L Lenz, A A Taylor
Clinical Pharmacology and Therapeutics
|
December 1, 1986
Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist
E B Nelson, J L Pool, A A Taylor
The American Journal of Medicine
|
September 23, 1988
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients
J L Pool, E B Nelson, A A Taylor
Bulletin of the New York Academy of Medicine
|
March 25, 2009
General Discussion
J L Pool, E S Goldensohn, H H Merritt
The American Journal of Medicine
|
October 31, 1986
Pharmacology of angiotensin converting enzyme inhibitors. A review
E B Nelson, J L Pool, A A Taylor
Stroke
|
May 1, 1971
Adrenergic blockade of hypocapnic cerebral arterial constriction
R A Fraser, B M Stein, J L Pool
The American Journal of Medicine
|
August 16, 1989
Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension
J L Pool, A A Taylor, E B Nelson
Journal of Human Hypertension
|
May 20, 1999
Dose-response efficacy of valsartan, a new angiotensin II receptor blocker
J L Pool, R Glazer, Y T Chiang, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine
|
January 1, 1972
The role of radiotherapy and chemotherapy in the surgical management of pulmonary metastases
A D Turnbull, J L Pool, K Arthur, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
The Journal of Urology
|
February 1, 1988
Isolated renal artery dissection secondary to medial degeneration
R Goldfarb, J L Pool, T Wheeler
Journal of Human Hypertension
|
October 1, 1990
Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations
J L Pool, M L Lenz, A A Taylor
Clinical Pharmacology and Therapeutics
|
December 1, 1986
Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist
E B Nelson, J L Pool, A A Taylor
The American Journal of Medicine
|
September 23, 1988
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients
J L Pool, E B Nelson, A A Taylor
Bulletin of the New York Academy of Medicine
|
March 25, 2009
General Discussion
J L Pool, E S Goldensohn, H H Merritt
The American Journal of Medicine
|
October 31, 1986
Pharmacology of angiotensin converting enzyme inhibitors. A review
E B Nelson, J L Pool, A A Taylor
Stroke
|
May 1, 1971
Adrenergic blockade of hypocapnic cerebral arterial constriction
R A Fraser, B M Stein, J L Pool
The American Journal of Medicine
|
August 16, 1989
Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension
J L Pool, A A Taylor, E B Nelson
Journal of Human Hypertension
|
May 20, 1999
Dose-response efficacy of valsartan, a new angiotensin II receptor blocker
J L Pool, R Glazer, Y T Chiang, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine
|
January 1, 1972
The role of radiotherapy and chemotherapy in the surgical management of pulmonary metastases
A D Turnbull, J L Pool, K Arthur, et al.
Page
of 9